📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

biOasis Technologies Inc (BTIh)

TSXV
Currency in CAD
Disclaimer
0.0050
0.0000(0.00%)
Delayed Data
BTIh Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
Fair Value
Day's Range
0.00500.0050
52 wk Range
0.00500.0100
Prev. Close
0.005
Open
0.005
Day's Range
0.005-0.005
52 wk Range
0.005-0.01
Volume
0
Average Volume (3m)
5,250
1-Year Change
-50%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
BTIh Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

biOasis Technologies Inc Company Profile

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company’s in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane’s OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis’ xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Compare BTIh to Peers and Sector

Metrics to compare
BTIh
Peers
Sector
Relationship
P/E Ratio
0.0x−3.8x−0.6x
PEG Ratio
0.000.180.00
Price/Book
0.0x2.0x2.6x
Price / LTM Sales
0.0x19.3x3.3x
Upside (Analyst Target)
0.0%124.7%44.5%
Fair Value Upside
Unlock−4.3%6.0%Unlock

FAQ

What Is the biOasis Technologies Inc (BTIh) Stock Price Today?

The biOasis Technologies Inc stock price today is 0.005

What Stock Exchange Does biOasis Technologies Inc Trade On?

biOasis Technologies Inc is listed and trades on the TSXV stock exchange.

What Is the Stock Symbol for biOasis Technologies Inc?

The stock symbol for biOasis Technologies Inc is "BTIh."

What Is the biOasis Technologies Inc Market Cap?

As of today, biOasis Technologies Inc market cap is 397.07K.

What is biOasis Technologies Inc Earnings Per Share?

The biOasis Technologies Inc EPS is -0.038.

What Is the Next biOasis Technologies Inc Earnings Date?

biOasis Technologies Inc will release its next earnings report on Oct 28, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.